637 related articles for article (PubMed ID: 30852163)
1. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
[TBL] [Abstract][Full Text] [Related]
2. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
3. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
[TBL] [Abstract][Full Text] [Related]
6. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
Rieg S; Huth A; Kalbacher H; Kern WV
Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
[TBL] [Abstract][Full Text] [Related]
7. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
[TBL] [Abstract][Full Text] [Related]
8. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
11. oprM as a new target for reversion of multidrug resistance in Pseudomonas aeruginosa by antisense phosphorothioate oligodeoxynucleotides.
Wang H; Meng J; Jia M; Ma X; He G; Yu J; Wang R; Bai H; Hou Z; Luo X
FEMS Immunol Med Microbiol; 2010 Dec; 60(3):275-82. PubMed ID: 20955466
[TBL] [Abstract][Full Text] [Related]
12. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
Puzari M; Chetia P
World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
[TBL] [Abstract][Full Text] [Related]
13. Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.
Paltansing S; Tengeler AC; Kraakman ME; Claas EC; Bernards AT
Microb Drug Resist; 2013 Dec; 19(6):469-76. PubMed ID: 23909485
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
[TBL] [Abstract][Full Text] [Related]
16. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
[TBL] [Abstract][Full Text] [Related]
17. CRP regulator modulates multidrug resistance of Escherichia coli by repressing the mdtEF multidrug efflux genes.
Nishino K; Senda Y; Yamaguchi A
J Antibiot (Tokyo); 2008 Mar; 61(3):120-7. PubMed ID: 18503189
[TBL] [Abstract][Full Text] [Related]
18. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a structural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance.
Wong KK; Brinkman FS; Benz RS; Hancock RE
J Bacteriol; 2001 Jan; 183(1):367-74. PubMed ID: 11114937
[TBL] [Abstract][Full Text] [Related]
20. Premature Termination of MexR Leads to Overexpression of MexAB-OprM Efflux Pump in Pseudomonas aeruginosa in a Tertiary Referral Hospital in India.
Choudhury D; Ghose A; Dhar Chanda D; Das Talukdar A; Dutta Choudhury M; Paul D; Maurya AP; Chakravarty A; Bhattacharjee A
PLoS One; 2016; 11(2):e0149156. PubMed ID: 26866484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
